Flowcytometric study of expression of perforin and CD134 in patients with systemic lupus erythematosus.
Abo-Elenein
Amany
A
Department of Clinical Pathology, Faculty of Medicine, Tanta University, Egypt.
Shaaban
Dalia
D
Gheith
Osama
O
D000293:Adolescent; D000328:Adult; D017252:CD3 Complex / Q000378:metabolism; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism; D005260:Female; D005434:Flow Cytometry / Q000379:methods*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D008297:Male; D054353:Perforin / Q000096:biosynthesis*; D011507:Proteinuria / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D053262:Receptors, OX40 / Q000096:biosynthesis*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology / Q000378:metabolism; D055815:Young Adult
D017252:CD3 Complex; D053262:Receptors, OX40; C505716:TNFRSF4 protein, human; D054353:Perforin